Table 1_Body composition–based nutritional status during neoadjuvant chemotherapy and its

Guoqing Shi's study on figshare, last updated April 2026, investigates body composition changes in gastric cancer patients undergoing neoadjuvant chemotherapy. The dataset likely contains measurements of muscle mass, skeletal muscle mass, body fat mass, visceral fat area, and water content before and after treatment. It explores associations between these changes and clinical outcomes like relative dose intensity and hematologic toxicity.

Use Cases

• Predicting risk of reduced chemotherapy dose intensity based on pre-treatment body composition metrics.
• Modeling associations between changes in muscle mass and the incidence of grade 2 thrombocytopenia.
• Analyzing correlations between visceral fat area and hematological toxicity outcomes mentioned in the study.

Strengths

• Dataset is openly licensed under CC-BY-4.0.
• Study design includes specific, measured body composition parameters (e.g., muscle mass, visceral fat area).
• Analysis includes odds ratios for specific outcomes, suggesting structured statistical results.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data file is a 47.7 KB DOCX, indicating a very small, likely summary-level dataset.

Provenance

Source

figshare, author Guoqing Shi.

Collection Method

Body composition parameters were measured via an InBody 720 analyzer before and after neoadjuvant therapy.

Time Range

Study period is not specified.

Freshness

Last updated 2026-04-16 04:19:10; freshness should be verified.

Geography

Geographic coverage of the patient population is not specified.